Displaying drugs 776 - 800 of 1169 in total
Bethanechol
Bethanechol is a synthetic ester that was initially synthesized in 1935.[A232905,L32539] As a cholinergic agent, bethanechol is similar in structure and pharmacological function to acetylcholine and is used in specific cases when stimulation of the parasympathetic nervous system is necessary.[A232905,L32539] For example, bethanechol is readily used to treat postoperative or...
Approved
Matched Synonyms: … Carbamyl-beta-methylcholine ... Carbamoyl-beta-methylcholine …
Matched Description: … [A232905,L32539] As a cholinergic agent, bethanechol is similar in structure and pharmacological function ... to acetylcholine and is used in specific cases when stimulation of the parasympathetic nervous system …
Matched Description: … [A232905,L32539] As a cholinergic agent, bethanechol is similar in structure and pharmacological function ... to acetylcholine and is used in specific cases when stimulation of the parasympathetic nervous system …
Bis-Napthyl Beta-Ketophosphonic Acid
Experimental
Matched Name: … Bis-Napthyl Beta-Ketophosphonic Acid …
1-Beta-Ribofuranosyl-1,3-Diazepinone
Experimental
Matched Name: … 1-Beta-Ribofuranosyl-1,3-Diazepinone …
Methoxy polyethylene glycol-epoetin beta
Methoxy polyethylene glycol-epoetin beta is a chemically synthesised Erythropoiesis Stimulating Agent (ESA) with a longer half-life than erythropoietin. ESA is used to increase synthesis of red blood cells to treat chronic kidney disease associated anemia.
Approved
Matched Name: … Methoxy polyethylene glycol-epoetin beta …
Matched Description: … Methoxy polyethylene glycol-epoetin beta is a chemically synthesised Erythropoiesis Stimulating Agent …
Matched Categories: … Amino Acids, Peptides, and Proteins ... Blood and Blood Forming Organs ... methoxy polyethylene glycol-epoetin beta ... Intercellular Signaling Peptides and Proteins …
Matched Description: … Methoxy polyethylene glycol-epoetin beta is a chemically synthesised Erythropoiesis Stimulating Agent …
Matched Categories: … Amino Acids, Peptides, and Proteins ... Blood and Blood Forming Organs ... methoxy polyethylene glycol-epoetin beta ... Intercellular Signaling Peptides and Proteins …
alpha-Keto-beta-methylvaleric acid
Experimental
Matched Name: … alpha-Keto-beta-methylvaleric acid …
Matched Salts name: … Calcium alpha-Keto-beta-methylvaleric acid …
Matched Salts name: … Calcium alpha-Keto-beta-methylvaleric acid …
Angelica archangelica root
Angelica archangelica root is a plant/plant extract used in some OTC (over-the-counter) products. It is not an approved drug.
Approved
Experimental
Matched Synonyms: … Archangelica Officinalis Root Extract …
Methyl 4-thio-beta-D-glucopyranoside
Experimental
Matched Name: … Methyl 4-thio-beta-D-glucopyranoside …
Cytidine-5'-diphospho-beta-D-xylose
Experimental
Matched Name: … Cytidine-5'-diphospho-beta-D-xylose …
2'-Deoxy-thymidine-beta-L-rhamnose
Experimental
Matched Name: … 2'-Deoxy-thymidine-beta-L-rhamnose …
Matched Categories: … Nucleic Acids, Nucleotides, and Nucleosides …
Matched Categories: … Nucleic Acids, Nucleotides, and Nucleosides …
Adenosine-5'-[Beta, Gamma-Methylene]Triphosphate
Experimental
Matched Name: … Adenosine-5'-[Beta, Gamma-Methylene]Triphosphate …
Imatinib
Imatinib is a small molecule kinase inhibitor that revolutionized the treatment of cancer, particularly chronic myeloid leukemia, in 2001. It was deemed a "miracle drug" due to its clinical success, as oncologist Dr. Brian noted that "complete hematologic responses were observed in 53 of 54 patients with CML treated with...
Approved
Matched Description: … responses were observed in 53 of 54 patients with CML treated with a daily dosage of 300 mg or more and ... [L42220]
Imatinib was approved on February 1st ,2001 by the FDA and November 7th, 2001 by the EMA …
Matched Categories: … Antineoplastic and Immunomodulating Agents ... Benzamides and benzamide derivatives …
Matched Products: … IMATINIB BETA 100MG ... IMATINIB BETA 400MG ... IMATINIB BASICS 100MG …
Matched Categories: … Antineoplastic and Immunomodulating Agents ... Benzamides and benzamide derivatives …
Matched Products: … IMATINIB BETA 100MG ... IMATINIB BETA 400MG ... IMATINIB BASICS 100MG …
Diosmetin
Diosmetin is an O-methylated flavone and the aglycone part of the flavonoid glycosides diosmin that occurs naturally in citrus fruits . Pharmacologically, diosmetin is reported to exhibit anticancer, antimicrobial, antioxidant, oestrogenic and anti-inflamatory activities . It also acts as a weak TrkB receptor agonist .
Experimental
Matched Description: … Diosmetin is an O-methylated flavone and the aglycone part of the flavonoid glycosides diosmin that occurs ... Pharmacologically, diosmetin is reported to exhibit anticancer, antimicrobial, antioxidant, oestrogenic and …
Matched Products: … Whoo Gongjinhyang Seol Whitening Jin Essence …
Matched Products: … Whoo Gongjinhyang Seol Whitening Jin Essence …
Ladostigil
Ladostigil is under investigation in clinical trial NCT01429623 (A 3 Year Study to Evaluate the Safety and Efficacy of Low Dose Ladostigil in Patients With Mild Cognitive Impairment).
Investigational
Matched Synonyms: … Tv-3326 free base …
Matched Description: … Ladostigil is under investigation in clinical trial NCT01429623 (A 3 Year Study to Evaluate the Safety and …
Matched Description: … Ladostigil is under investigation in clinical trial NCT01429623 (A 3 Year Study to Evaluate the Safety and …
Opiranserin
Opiranserin is under investigation in clinical trial NCT03997838 (Evaluate the Efficacy and Safety of VVZ-149 Injections for the Treatment of Post-operative Pain Following Abdominoplasty).
Investigational
Matched Synonyms: … Vvz-149 free base …
Matched Description: … Opiranserin is under investigation in clinical trial NCT03997838 (Evaluate the Efficacy and Safety of …
Matched Description: … Opiranserin is under investigation in clinical trial NCT03997838 (Evaluate the Efficacy and Safety of …
4-(Hydrogen sulfate)-beta-D-galactopyranose
Experimental
Matched Synonyms: … 4-(Hydrogen sulfate)-beta-D-galactopyranose …
Matched Name: … 4-(Hydrogen sulfate)-beta-D-galactopyranose …
Matched Name: … 4-(Hydrogen sulfate)-beta-D-galactopyranose …
N-[4-([(2-Amino-4-oxo-1,4-dihydropyrido[3,2-d]pyrimidin-6-yl)methyl]{(2E)-3-[4-carbamoyl-1-(5-O-phosphono-beta-D-ribofuranosyl)-1H-imidazol-5-yl]-2-propenoyl}amino)benzoyl]-L-glutamic acid
Experimental
Matched Synonyms: … beta-DADF, MSA, multisubstrate adduct inhibitor …
Matched Name: … [(2-Amino-4-oxo-1,4-dihydropyrido[3,2-d]pyrimidin-6-yl)methyl]{(2E)-3-[4-carbamoyl-1-(5-O-phosphono-beta-D-ribofuranosyl …
Matched Name: … [(2-Amino-4-oxo-1,4-dihydropyrido[3,2-d]pyrimidin-6-yl)methyl]{(2E)-3-[4-carbamoyl-1-(5-O-phosphono-beta-D-ribofuranosyl …
Cannabidiol
Cannabidiol, or CBD, is one of at least 85 active cannabinoids identified within the Cannabis plant. It is a major phytocannabinoid, accounting for up to 40% of the Cannabis plant's extract, that binds to a wide variety of physiological targets of the endocannabinoid system within the body. Although the exact...
Approved
Investigational
Matched Synonyms: … (−)-trans-2-p-mentha-1,8-dien-3-yl-5-pentylresorcinol …
Matched Description: … On June 25th, 2018, Epidiolex was approved by the FDA to be the first CBD-based product available on ... , and physiological effects. ... 2 (CB1 and CB2)[A32585,A32824]. …
Matched Categories: … Cannabinoids and similars …
Matched Description: … On June 25th, 2018, Epidiolex was approved by the FDA to be the first CBD-based product available on ... , and physiological effects. ... 2 (CB1 and CB2)[A32585,A32824]. …
Matched Categories: … Cannabinoids and similars …
Olanzapine
Olanzapine is a thienobenzodiazepine classified as an atypical or second-generation antipsychotic agent. The second-generation antipsychotics were introduced in the 90s and quickly gained traction due to their impressive efficacy, reduced risk for extrapyramidal side effects and reduced susceptibility to drug-drug interactions. Olanzapine very closely resembles clozapine and only differs by...
Approved
Investigational
Matched Description: … and the absence of a chloride moiety. ... [A176996] The second-generation antipsychotics were introduced in the 90s and quickly gained traction ... due to their impressive efficacy, reduced risk for extrapyramidal side effects and reduced susceptibility …
Matched Mixtures name: … Olanzapine and Fluoxetine ... Olanzapine and Fluoxetine ... Olanzapine and Fluoxetine …
Matched Categories: … olanzapine and samidorphan ... Diazepines, Oxazepines, Thiazepines and Oxepines …
Matched Products: … OLANZAPIN BETA 5MG ... OLANZAPIN BETA 10MG ... OLANZAPIN BETA 15MG …
Matched Mixtures name: … Olanzapine and Fluoxetine ... Olanzapine and Fluoxetine ... Olanzapine and Fluoxetine …
Matched Categories: … olanzapine and samidorphan ... Diazepines, Oxazepines, Thiazepines and Oxepines …
Matched Products: … OLANZAPIN BETA 5MG ... OLANZAPIN BETA 10MG ... OLANZAPIN BETA 15MG …
Dideoxyadenosine
Investigational
Matched Synonyms: … 6-amino-9-(2',3'-dideoxy-.beta.-d-glycero-pentofuranosyl)purine ... 9-(2,3-dideoxy-.beta.-d-glycero-pentofuranosyl)-9h-purin-6-amine …
Matched Categories: … Nucleic Acids, Nucleotides, and Nucleosides …
Matched Categories: … Nucleic Acids, Nucleotides, and Nucleosides …
Anagrelide
Anagrelide is a platelet-reducing agent used to lower dangerously elevated platelet levels (i.e. to treat thrombocythemia) in patients with myeloproliferative neoplasms. It is an oral imidazoquinazoline that was first approved for use in the US in 1997. It appears to carry a better response rate than other thrombocythemia treatments (e.g....
Approved
Matched Description: … [busulfan], [hydroxyurea]) and may be better tolerated.[A214274] …
Matched Categories: … Antineoplastic and Immunomodulating Agents …
Matched Products: … ANAGRELID BETA 0.5MG HARTK …
Matched Categories: … Antineoplastic and Immunomodulating Agents …
Matched Products: … ANAGRELID BETA 0.5MG HARTK …
Duloxetine
Duloxetine is a dual serotonin and norepinephrine reuptake inhibitor.[label] It was originally discovered in 1993 and developed by Eli Lilly and Company as LY248686. Duloxetine first received approval from the FDA in August, 2004 as Cymbalta for the treatment of Major Depressive Disorder. It has since received approval for a...
Approved
Matched Description: … [label] It was originally discovered in 1993 and developed by Eli Lilly and Company as LY248686. ... Duloxetine is a dual serotonin and norepinephrine reuptake inhibitor. ... Duloxetine continues to be investigated for the treatment of pain in cancer, surgery, and more. …
Matched Categories: … Serotonin and Noradrenaline Reuptake Inhibitors …
Matched Products: … DULOXETIN BETA 30MG ... DULOXETIN BETA 45MG ... DULOXETIN BETA 60MG …
Matched Categories: … Serotonin and Noradrenaline Reuptake Inhibitors …
Matched Products: … DULOXETIN BETA 30MG ... DULOXETIN BETA 45MG ... DULOXETIN BETA 60MG …
Displaying drugs 776 - 800 of 1169 in total